International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-1 doi: 10.5281/zenodo.10648652
Original Article
Comparative Study of Functional Outcome of Subvastus Versus Medial Parapatellar Approach Following Total Knee Arthroplasty
 ,
 ,
 ,
Published
Feb. 8, 2024
Abstract

Background: Total knee arthroplasty (TKA) is a common orthopedic procedure aimed at alleviating pain and restoring function in patients with knee osteoarthritis. The choice of surgical approach can significantly impact postoperative outcomes, particularly in terms of recovery speed and pain management.

Methods: This summary synthesizes findings from multiple studies comparing the subvastus (SV) and medial parapatellar (MPP) approaches in TKA. The focus is on early functional outcomes, including quadriceps strength recovery and pain reduction.

Results: Patients undergoing TKA via the SV approach demonstrated a quicker return of quadriceps strength and slightly better pain scores in the immediate postoperative period. Specifically, a 0.8-point improvement in pain scores (95% CI 0.22 to 1.35) was noted in favor of the SV approach compared to the MPP approach.

Conclusion: The SV approach to TKA offers advantages in terms of faster postoperative recovery, particularly with regard to quadriceps strength and pain management. These benefits highlight the role of tissue-sparing surgical techniques in enhancing patient outcomes after knee arthroplasty

Recommended Articles
Loading Image...
Volume-5, Issue-1
Citations
782 Views
364 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved